Raaj Medisafe Peer Comparison

BSE: 524502

₹102.51

₹0.01 (0.01%)

As on 30-Oct-2026IST

Market cap

₹168 Cr

Revenue (TTM)

₹94 Cr

P/E Ratio

71.1

P/B Ratio

3.5

Div. Yield

0 %

Edit

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Market cap (₹ Cr)	168	14,676	350	285	197
Revenue (₹ Cr)	94	1,997	183	174	34
Net Profit (₹ Cr)	2.37	307.01	12.72	4.76	-4.78
Net Margin (%)	2.51	14.56	6.90	2.64	-13.48
RoE (%)	6.25	10.63	10.39	2.58	-30.48
Price to Earnings	71.07	46.58	32.18	59.90	--
Price-To-Book	3.46	4.61	--	1.52	11.21

Income Statement (₹ Cr)

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Operating Revenue	80.01	1,875.26	--	146.96	28.69
Total Income	80.58	2,002.19	--	155.06	30.94
Total Expenditure	68.25	1,436.66	--	146.78	26.75
EBITDA	11.76	438.59	--	0.18	1.94
Depreciation	2.04	115.52	--	2.02	3.80
EBIT	9.72	323.08	--	-1.84	-1.86
Interest	3.96	21.42	--	1.28	2.20
Other Income	0.56	126.93	--	8.10	2.25
Exceptional Items	--	-6.80	--	--	--
Profit before Tax	6.32	427.47	--	4.98	-1.82
Provision for Tax	4.51	106.74	--	2.90	--
Profit after Tax	1.81	320.73	--	2.08	-1.82

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Shareholder's Funds	46.74	3,106.17	--	180.76	1.77
Minority Interest	--	43.07	--	--	-0.58
Non-Current Liabilities	39.30	120.16	--	-0.92	19.69
Current Liabilities	35.31	666.53	--	13.78	6.37
Total Liabilities	121.35	3,951.60	--	196.16	27.25

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Non-Current Assets	70.90	1,903.19	--	78.94	18.03
Current Assets	50.45	2,032.74	--	114.68	9.21
Total Assets	121.35	3,951.60	--	196.16	27.25
Total Debt*	64.13	341.62	--	0.72	7.38
Net Current Assets	15.14	1,366.21	--	100.90	2.85
Contingent Liabilities	--	50.21	--	4.73	--

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Cash From Operating Activities	3.67	246.37	--	3.30	-1.68
Cash Flow from Investing Activities	-34.95	-225.38	--	14.49	1.92
Cash from Financing Activities	44.23	20.15	--	-19.56	-1.98
Net Cash Inflow / Outflow	12.95	41.14	--	-1.77	-1.74

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
ROCE (%)	11.94	14.05	--	3.31	3.64
ROE (%)	4.91	10.94	--	1.11	-71.25
ROA (%)	1.91	8.89	--	1.04	-6.59
EBIT Margin (%)	15.41	30.16	--	5.63	14.60
Net Margin (%)	2.25	16.02	--	1.34	-5.87
Cash Profit Margin (%)	4.81	23.12	--	2.57	6.93

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Revenue Growth (%)	28.19	12.30	--	34.02	149.39
EBIT Growth (%)	39.58	3.80	--	69.11	1,282.42
Net Profit Growth (%)	-70.48	-5.27	--	145.86	48.05
EPS Growth (%)	-76.32	-4.88	--	157.91	48.32
Book Value Growth (%)	73.66	12.14	--	-6.96	-46.81

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Price / Earnings	64.26	37.47	--	94.46	0.00
Price / Book Value	2.49	3.90	--	1.09	36.61
Dividend Yield (%)	0.00	0.29	--	0.00	0.00
EV/EBITDA	13.58	21.79	--	18.84	17.05
Market Cap (₹ Cr)	116.30	12,069.92	--	196.67	64.81

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Debt to Equity	1.37	0.11	--	0.00	4.17
Short term debt to equity ratio	0.44	0.08	--	0.00	0.16
Current Ratio	1.43	3.05	--	8.32	1.45
Quick Ratio	1.01	2.40	--	4.88	0.79
Interest Coverage	2.60	20.96	--	4.88	0.17

	Raaj Medisafe	Poly Medicure	QMS Medical	Nureca	Alan Scott
Debtors to sales (%)	14.69	28.33	--	5.27	2.17
Asset Turnover	0.85	0.52	--	0.80	1.04
Receivable days	64.89	85.20	--	12.70	6.55
Inventory Days	52.52	69.58	--	100.27	52.69
Payable days	33.26	77.97	--	22.92	33.92
Cash Conversion Cycle	84.16	76.82	--	90.04	25.31

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.